Bioventus (BVS)
(Delayed Data from NSDQ)
$11.79 USD
-0.16 (-1.34%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $11.78 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (88 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.33 | 1.56 | 9.99 |
Current Quarter Estimate | 0.06 | 0.26 | 61.00 |
Year Ago Quarter Estimate | 0.05 | -0.05 | 54.84 |
Next Quarter Estimate | 0.09 | -1.84 | 63.00 |
Next Year Estimate | 0.45 | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 1,900.00 | 20.00 | 15.67 |
Next Year | 12.50 | 17.00 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 31.45 | -2.09 |
Price/Book (MRQ) | 5.12 | 1.51 |
Price/Cash Flow (MRFY) | 15.11 | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -7.82% | -56.43% |
Return on Equity (TTM) | 14.39% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.